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Antibiotic-Induced Mutagenesis: Under the Microscope
Abstract
Copyright 2020 Revitt-Mills and Robinson. The development of antibiotic resistance poses an increasing
threat to global health. Understanding how resistance develops in bacteria is critical for the advancement
of new strategies to combat antibiotic resistance. In the 1980s, it was discovered that certain antibiotics
induce elevated rates of mutation in bacteria. From this, an "increased evolvability" hypothesis was
proposed: antibiotic-induced mutagenesis increases the genetic diversity of bacterial populations, thereby
increasing the rate at which bacteria develop antibiotic resistance. However, antibiotic-induced
mutagenesis is one of multiple competing factors that act on bacterial populations exposed to
antibiotics. Its relative importance in shaping evolutionary outcomes, including the development of
antibiotic resistance, is likely to depend strongly on the conditions. Presently, there is no quantitative
model that describes the relative contribution of antibiotic-induced mutagenesis to bacterial evolution. A
far more complete understanding could be reached if we had access to technology that enabled us to
study antibiotic-induced mutagenesis at the molecular-, cellular-, and population-levels simultaneously.
Direct observations would, in principle, allow us to directly link molecular-level events with outcomes in
individual cells and cell populations. In this review, we highlight microscopy studies which have allowed
various aspects of antibiotic-induced mutagenesis to be directly visualized in individual cells for the first
time. These studies have revealed new links between error-prone DNA polymerases and recombinational
DNA repair, evidence of spatial regulation occurring during the SOS response, and enabled real-time
readouts of mismatch and mutation rates. Further, we summarize the recent discovery of stochastic
population fluctuations in cultures exposed to sub-inhibitory concentrations of bactericidal antibiotics and
discuss the implications of this finding for the study of antibiotic-induced mutagenesis. The studies
featured here demonstrate the potential of microscopy to provide direct observation of phenomena
relevant to evolution under antibiotic-induced mutagenesis.
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The development of antibiotic resistance poses an increasing threat to global health.
Understanding how resistance develops in bacteria is critical for the advancement of new
strategies to combat antibiotic resistance. In the 1980s, it was discovered that certain
antibiotics induce elevated rates of mutation in bacteria. From this, an “increased
evolvability” hypothesis was proposed: antibiotic-induced mutagenesis increases the
genetic diversity of bacterial populations, thereby increasing the rate at which bacteria
develop antibiotic resistance. However, antibiotic-induced mutagenesis is one of multiple
competing factors that act on bacterial populations exposed to antibiotics. Its relative
importance in shaping evolutionary outcomes, including the development of antibiotic
resistance, is likely to depend strongly on the conditions. Presently, there is no quantitative
model that describes the relative contribution of antibiotic-induced mutagenesis to bacterial
evolution. A far more complete understanding could be reached if we had access to
technology that enabled us to study antibiotic-induced mutagenesis at the molecular-,
cellular-, and population-levels simultaneously. Direct observations would, in principle,
allow us to directly link molecular-level events with outcomes in individual cells and cell
populations. In this review, we highlight microscopy studies which have allowed various
aspects of antibiotic-induced mutagenesis to be directly visualized in individual cells for
the first time. These studies have revealed new links between error-prone DNA polymerases
and recombinational DNA repair, evidence of spatial regulation occurring during the SOS
response, and enabled real-time readouts of mismatch and mutation rates. Further,
we summarize the recent discovery of stochastic population fluctuations in cultures
exposed to sub-inhibitory concentrations of bactericidal antibiotics and discuss the
implications of this finding for the study of antibiotic-induced mutagenesis. The studies
featured here demonstrate the potential of microscopy to provide direct observation of
phenomena relevant to evolution under antibiotic-induced mutagenesis.
Keywords: stress response, DNA damage, imaging, experimental evolution, recombination

ANTIBIOTIC-INDUCED MUTAGENESIS: FROM MOLECULES
TO CELLS TO POPULATIONS
Mutation is one of the two major mechanisms for the development of antibiotic resistance in
bacteria (Woodford and Ellington, 2007). In the laboratory, high-level resistance against most
antibiotics can be acquired by bacteria through the development of mutations (Woodford and
Ellington, 2007). In clinically relevant bacterial pathogens, resistance to most antibiotics is
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acquired through lateral gene transfer; however, mutational
resistance dominates in some circumstances. Resistance against
fluoroquinolones (Appelbaum and Hunter, 2000; Ruiz, 2003),
rifampicin (Gillespie, 2002), oxazolidinones (Long and Vester,
2012), fusidic acid (Nagaev et al., 2001; Besier et al., 2005),
and streptomycin (Gillespie, 2002) frequently arises through
mutation (Woodford and Ellington, 2007). Commonly these
are “target-gene mutations,” in which the systems that are
targeted by the antibiotic become altered in such a way that
the antibiotic no longer binds to its target or is otherwise
made ineffective. Another important class of mutations that
occur commonly among clinical isolates is loss-of-function
mutations in regulators that can lead to increased activity of
associated multi-drug efflux pumps (Woodford and Ellington,
2007). Interestingly, the causative agent of tuberculosis,
Mycobacterium tuberculosis, appears to acquire antibiotic
resistance exclusively through mutation, as opposed to lateral
gene transfer (Gillespie, 2002).
In many cases, we have a strong understanding of how
particular mutations lead to an increase in resistance against
a particular antibiotic (Woodford and Ellington, 2007). Much
is known about the molecular mechanisms that generate
mutations and the evolutionary dynamics that allow them to
fix within bacterial populations (Andersson and Hughes, 2017).
In the simplest scenario, mutations occur spontaneously, arising
from errors made during DNA synthesis (Martinez and Baquero,
2000). Mutants are present in the population prior to antibiotic
exposure and are strongly selected for once the population is
exposed (Martinez and Baquero, 2000). This spontaneous
mutation model serves as the null hypothesis in any study
seeking to uncover the origins of a particular antibiotic resistance
mutation. It is known, however, that some antibiotics can
induce higher mutation rates in bacteria (Mao et al., 1997;
Oliver et al., 2000; Blazquez et al., 2018). The role of induced
mutagenesis in the evolution of antibiotic resistance remains
a lively field of research (Blazquez et al., 2018).
Exposure to antibiotics can elevate mutation rates in bacteria
in two ways. Both mechanisms have demonstrated capacity
to drive the development of antibiotic resistance in laboratory
models (Cirz et al., 2005; Pribis et al., 2019). First, antibiotic
exposure often leads to the selection of hypermutator phenotypes;
cells that have developed constitutively high mutation rates
(Mao et al., 1997; Oliver et al., 2000; Shaver et al., 2002;
Blazquez, 2003; Durao et al., 2018). These usually arise from
loss-of-function mutations in systems that normally help to
maintain low mutation rates, such as mismatch repair enzymes
or proofreading exonucleases (Miller et al., 1999; RodriguezRojas et al., 2013; Durao et al., 2018). Second, exposure to
antibiotics can induce elevated mutation rates directly, by
promoting the activities of error-prone DNA repair systems
or by temporarily down-regulating mismatch repair (Frisch
et al., 2010; Shee et al., 2011a). It is this second class of
phenomena, termed antibiotic-induced mutagenesis or transient
hypermutation, that is the primary focus of this review.
Antibiotic-induced mutagenesis is most often linked to the
SOS response; a transcriptional program that upregulates a
set of genes (~40 in Escherichia coli), most of which have
Frontiers in Microbiology | www.frontiersin.org

functions relevant to DNA damage (Blazquez et al., 2018;
Maslowska et al., 2019). Included in the SOS regulon are genes
that encode error-prone DNA polymerases (Goodman and
Woodgate, 2013; Joseph and Badrinarayanan, 2020). During
the SOS response, error-prone polymerases increase the rate
at which mutations appear in cells (Kuban et al., 2004; Hastings
et al., 2010; Blazquez et al., 2018). In this way, antibiotic
exposure begets mutagenesis. The observation of antibioticinduced mutagenesis led to the proposal of an “increased genetic
diversity” hypothesis in the early 2000s: antibiotic-induced
mutagenesis drives an increase in the genetic diversity of bacterial
populations and thus speeds the development of mutational
antibiotic resistance (Radman, 1999; Martinez and Baquero,
2000; Rosenberg, 2001; Cirz et al., 2005). Twenty years later,
this idea remains an active field of study (Blazquez et al., 2018).
There is ample evidence that antibiotic-induced mutagenesis
occurs. Much of this evidence has been reviewed in detail
recently (Blazquez et al., 2018). The primary question facing
the field is: does it matter? Does the potential increase in
mutation supply brought on by antibiotic-induced mutagenesis
ever outweigh the loss of diversity brought on by the antibiotic
killing the cells? To our knowledge, only one experimental
evolution study has specifically investigated whether antibioticinduced mutagenesis can play a dominant role in the evolution
of antibiotic resistance. This study, which monitored the de
novo appearance of ciprofloxacin-resistance mutations in a
mouse infection model strongly suggested that resistance was
dependent on antibiotic-induced mutagenesis (Cirz et al., 2005).
As detailed below, assessing the role of antibiotic-induced
mutagenesis in evolution requires that the effects of an antibiotic
on mutagenesis are experimentally isolated from its effects on
cell survival. Currently, this is almost impossible to do in
animal models and this ultimately limits the use of top-down
approaches toward studying evolution under antibiotic-induced
mutagenesis. At the other end of the spectrum, observations
made at the level of individual cells and small populations of
cells may provide sufficient insight to enable accurate computer
modeling of events that are too complex to monitor directly.
With enough data, collected under carefully controlled conditions,
this offers a potential means to approach the antibiotic-induced
mutagenesis problem from the bottom-up.
Antibiotic-induced mutagenesis will only influence evolutionary
outcomes in situations where the bacterial cells remain alive
long enough to produce new mutations. Thus, it is likely that
it occurs infrequently under high antibiotic concentrations,
where most cells die quickly. For this reason, antibiotic-induced
mutagenesis is typically studied at antibiotic concentrations close
to, but below, the minimum inhibitory concentration (MIC).
The evolutionary dynamics at play within this near-MIC regime
are more complex than those that occur at lethal concentrations
of antibiotic (Figure 1). At concentrations near the MIC, selection
for resistant variants will be weaker than for concentrations
above MIC, although it is important to note that many antibiotics
remain selective at concentrations far below the MIC (Andersson
and Hughes, 2014). Near to the MIC, population genetics will
play a major role in determining evolutionary outcomes
(Hughes and Andersson, 2017). Competition for resources
2
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FIGURE 1 | Antibiotic-induced mutagenesis is one of many factors that influence genetic diversity in bacterial populations. Many antibiotics induce elevated rates
of mutagenesis in bacterial cells. However, the relative importance of antibiotic-induced mutagenesis in shaping the evolution of antibiotic resistance remains unclear.
This figure illustrates some of the competing factors that increase and decrease genetic diversity (i.e., number of unique mutants) in antibiotic-exposed bacteria. It is
not intended to serve as a functional model of resistance development. An initial population of antibiotic-naïve cells appears in the center. The majority of cells in the
population are of the major genotype (“wild type”; gray circles). Due to there being a basal rate of spontaneous mutagenesis, some cells have variant genotypes
(colored circles). The left panels depict a scenario in which a lethal dose of bactericidal antibiotics is administered. Under these conditions, the rate of cell death
outpaces the rate of cell division. In the first stage of this inhibitory concentration scenario, most of the population is killed (circles disappear). A few cells initially
survive long enough to divide, however, in time these are also killed. Thus, no cells remain alive by the second stage of the scenario. Because there is little cell
growth, there is little scope for antibiotic-induced mutagenesis. The genetic diversity of the population crashes as rapid cell death dominates over other factors. Any
antibiotic-resistant mutants that are selected under these conditions are likely to be pre-existing in the population prior to antibiotic exposure. In the second
scenario, depicted in the two right panels, a sub-inhibitory concentration of a bactericidal antibiotic is applied. As demonstrated recently (Coates et al., 2018), many
cells die under these conditions, however, the rate of cell division outpaces the rate of cell death, leading to net population growth. In the first stage of this
sub-inhibitory concentration scenario, a portion of cells die (~30%), while the remaining cells divide (~70%). Antibiotic-induced mutagenesis increases the probability
that variants are produced during these cell divisions (gray circles more often yield colored circles). Specific examples of each event are depicted with arrows (i–iv;
see example events legend). These processes of stochastic cell death, cell division, and mutagenesis are repeated in the second stage. Over time, the population
becomes larger and contains a greater number of variants than the initial population. It is important to note, however, that the number of cell divisions required to
reach a particular population size will be higher than what would be required in the absence of drug. Many experimental measures of induced mutagenesis rates
neglect this behavior and will therefore be overestimated if cell death is occurring frequently (Frenoy and Bonhoeffer, 2018). Nevertheless, antibiotic-induced
mutagenesis can significantly contribute to the development of antibiotic resistance in vivo (Cirz et al., 2005). Overall, the genetic diversity of the population in the
sub-inhibitory concentration scenario will depend on the complex interplay between cell death, cell division, spontaneous mutagenesis, and induced mutagenesis.
Selection for antibiotic-resistant phenotypes will occur at all stages and is likely to involve additional complexity arising from population-level phenomena that are not
depicted in the figure.

between variants (clonal interference) will play a large role
in determining the population structure (Hughes and
Andersson, 2017). Population size will also shape evolutionary
outcomes – large populations tend to disfavor the selection
of rare variants unless they are particularly advantageous
(Hughes and Andersson, 2017). The relative rates of cell
growth and cell death will also be important (Coates et al.,
2018). It is widely known that exposing cells to near-MIC
concentrations of bactericidal antibiotics causes the population
to grow at a diminished rate. However, it was only demonstrated
recently that this occurs because a portion of the population
undergoes stochastic cell death (Coates et al., 2018). Thus,
the population growth rate slows because the cell death rate
approaches the cell growth rate, rather than all the cells
simply growing at a slower rate. This phenomenon is depicted
in Figure 1 and is expanded upon in a later section. At the
same time that antibiotic-induced mutagenesis is acting to
increase genetic diversity (i.e., number of unique mutants)
within the population, cell death acts to reduce the size of
the population. Evolutionary outcomes, including the likelihood
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of the population becoming antibiotic resistant, will depend
strongly on the balance of these two parameters.
We propose that to better understand the role of antibioticinduced mutagenesis on the evolution of antibiotic-resistance
mutations, we need to be able to measure its effects while
simultaneously monitoring cell and population level behaviors.
This is not achievable with conventional microbiology techniques
(e.g., fluctuation analyses), which operate as end-point assays
and have indirect read-outs.
In recent years, researchers have begun to explore microscopy
as a means to obtain direct, real-time observations of individual
cells, and even individual molecules within them. The purpose
of the current review is to highlight studies in which microscopy
has improved our understanding of either the molecular
mechanisms underlying antibiotic-induced mutagenesis or celland population-level events that occur when bacteria are
challenged with sub-inhibitory concentrations of antibiotics.
Much of the microscopy work presented here has been conducted
in E. coli, due to its prevalence as a laboratory model organism,
and with fluoroquinolones because these drugs are strongly
3
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mutagenic and are commonly utilized as model compounds
in laboratory experiments. For a more comprehensive review
of antibiotic-induced mutagenesis, which includes work in other
systems, we suggest a recent review by Blazquez et al. (2018).
There remains tremendous scope to extend the studies highlighted
within this review to other organisms and other antibiotics.
While microscopy cannot resolve all of the gaps in knowledge
that remain open in the field of antibiotic-induced mutagenesis,
the studies highlighted in the current review demonstrate the
potential for enormous gains to be made. We anticipate that
the greatest impact of microscopy will be in improving our
understanding of how mutation rates are modulated in bacterial
cells and in mapping mutations to fitness effects.

THE CELLULAR CONTEXT OF
ANTIBIOTIC-INDUCED MUTAGENESIS

FIGURE 2 | Conditions inside bacterial cells undergoing antibiotic-induced
mutagenesis. With the exception of panels (A) and (G), all panels depict
Escherichia coli cells exposed to ciprofloxacin, a bactericidal antibiotic of the
fluoroquinolones class. (A,B) E. coli growing as rod-shaped cells in the
absence of antibiotics (A) and as filamentous cells in the presence of
ciprofloxacin (B). Figure adapted from Diver and Wise (1986). (C) Filamentous
E. coli cells contain multiple copies of the chromosome, as shown by DAPI
staining. The number of chromosomes scales with filament length.
Figure adapted from Bos et al. (2015). (D) Large numbers of DNA doublestrand breaks in ciprofloxacin-treated cells, as detected by a fluorescent protein
fusion of the Gam protein. Figure adapted from Pribis et al. (2019). (E,F)
Increased activity of fluorescently labeled error-prone DNA polymerases IV (E)
and V (F) in ciprofloxacin-treated cells, as visualized by single-molecule
fluorescence microscopy. Figures adapted from Henrikus et al. (2018, 2020).
(G) Large bundle of fluorescently labeled RecA formed in an E. coli cell that
contains a single DNA double-strand break induced via expression of the SceI
restriction enzyme. Figure adapted from Lesterlin et al. (2014).
(H) Colocalisation of error-prone DNA polymerase IV with RecA in ciprofloxacintreated cells. RecA-ssDNA nucleoprotein filaments (RecA*) are specifically
visualized using a portion of the RecA*-binding cI repressor protein that has
been fused to a fluorescent protein. Figure adapted from Henrikus et al. (2020).

Before discussing the molecular mechanisms of antibiotic-induced
mutagenesis, it is useful to consider the cellular context in which
it takes place. Elevated mutagenesis is induced by several classical
DNA-damaging agents, including UV light, mitomycin c, and
methyl methanesulfonate (Maslowska et al., 2019). It is likely that
all the antibiotics that induce mutagenesis do so by causing DNA
damage. This can occur as a direct consequence of their mode
of action (as is the case for fluoroquinolones, which inhibit type
II-topoisomerases). Alternatively, DNA damage can occur indirectly,
through errant metabolic processes that generate reactive-oxygen
species (ROS; Kohanski et al., 2010). In Figure 2, we summarize
some of the events known to take place in E. coli cells treated
with ciprofloxacin, a fluoroquinolone antibiotic that is a key model
compound in the study of antibiotic-induced mutagenesis (Cirz
et al., 2005; Zhang et al., 2011; Bos et al., 2015; Pribis et al.,
2019). It is likely that much of what we summarize for E. coli
cells treated with ciprofloxacin extends to other organisms and
to other antibiotics, although in most cases this remains to be tested.
Broadly speaking, E. coli cells respond to ciprofloxacin the
same way they do to sub-inhibitory doses of other DNA damaging
agents – they induce the SOS response (Pribis et al., 2019).
SOS induction has been measured directly for several
fluoroquinolones (Ysern et al., 1990; Thi et al., 2011; Pribis
et al., 2019; Rodriguez-Rosado et al., 2019), as well as for the
antifolates trimethoprim and sulfamethoxazole (Thi et al., 2011;
Blazquez et al., 2012), and representative members of the β-lactams
(Thi et al., 2011; Blazquez et al., 2012). Microscopy has revealed
much about how E. coli cells respond to ciprofloxacin treatment.
Once exposed, the cells continue to grow, but divide much less
often, causing them to form long filaments (Figures 2A,B; Diver
and Wise, 1986; Thi et al., 2011; Bos et al., 2015; Henrikus
et al., 2018; Pribis et al., 2019). Bulk DNA replication continues
during sub-inhibitory ciprofloxacin treatment (likely at a
diminished rate; Goss et al., 1965; Snyder and Drlica, 1979)
and as a result the filamentous cells contain multiple nucleoid
masses (Figure 2C; Bos et al., 2015). This suggests that filamentous
cells contain multiple independent (or semi-independent) copies
of the bacterial chromosome, although it is important to note
that the masses are less organized than the nucleoids of untreated
Frontiers in Microbiology | www.frontiersin.org

cells, and the study did not examine whether masses represent
intact or partially degraded nucleoids.
Cells treated with ciprofloxacin contain elevated numbers of
DNA double-strand breaks, which can be detected using fluorescent
fusions of the Gam protein from bacteriophage λ (Figure 2D;
Shee et al., 2013; Pribis et al., 2019). Detection of double-strand
breaks through a fluorescent protein fusion of the RecN protein
has also been reported (Hong et al., 2017). It is likely that cells
treated with other bactericidal compounds also contain large
numbers of breaks as a consequence of having elevated ROS
levels (Liu et al., 2010; Foti et al., 2012; Giroux et al., 2017).
We have detected significant numbers of breaks appearing in
cells treated with trimethoprim, for example (Henrikus et al.,
2020). Double-strand breaks are important lesions for antibioticinduced mutagenesis for multiple reasons. First, double-strand
breaks are considered to be lethal to cells if left unrepaired
(Cox, 2013). Second, the processing of double-strand breaks by
the RecBCD helicase-nuclease complex is one of the major triggers
for the induction of the SOS response in E. coli (Simmons et al.,
2008). This probably extends to other organisms such as Bacillus
subtilis, that uses the functional analog of RecBCD, AddAB
(Simmons et al., 2008). Third, much of the increased mutagenesis
associated with ciprofloxacin treatment in E. coli can be attributed
4
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to a form of error-prone double-strand break repair (Pribis et al.,
2019). This activity requires error-prone DNA polymerases IV
and V, induction of the SOS response (to produce sufficient
amounts of these polymerases), and induction of the RpoS
response (described in detail later), which plays a crucial, but
unidentified role. Using single-molecule fluorescence microscopy,
the activation of pols IV and V in cells exposed to ciprofloxacin
has now been observed directly (Figures 2E,F and section below;
Henrikus et al., 2018). Fourth, homologous recombination is the
primary mode of repair for double-strand breaks in E. coli
(Dillingham and Kowalczykowski, 2008). The presence of multiple
double-strand breaks in ciprofloxacin-treated cells (Figure 2D),
together with the presence of multiple chromosome equivalents
(Figure 2C), means that high levels of homologous recombination
are likely to take place between chromosome equivalents. Interchromosomal homologous recombination is thought to be mediated
through the formation of large structures by the RecA protein
(Figures 2G,H; Levin-Zaidman et al., 2000; Renzette et al., 2005;
Lesterlin et al., 2014; Ghodke et al., 2019). Inter-chromosomal
recombination has the potential to remove mutations, to introduce
mutations (through error-prone break repair), and to combine
mutations that originate within different chromosome variants
into a single chromosome (Guttman and Dykhuizen, 1994; Lopez
et al., 2007; Lopez and Blazquez, 2009; Pribis et al., 2019). In
E. coli, inter-chromosomal recombination is strongly stimulated
by exposure to ciprofloxacin (Lopez et al., 2007; Lopez and
Blazquez, 2009), but not by antibiotics outside of the
fluoroquinolone class (Lopez and Blazquez, 2009).
While the phenomena described above provide valuable
insight into events in cells that accompany antibiotic-induced
mutagenesis, they are by no means the only factors involved.
Environmental factors, including media composition, can
dramatically impact mutagenesis (Maharjan and Ferenci, 2017).
The intracellular production of ROS is demonstrated to
be important for mutagenesis induced by ciprofloxacin (Pribis
et al., 2019; Rodriguez-Rosado et al., 2019) and is highly likely
to be involved in mutagenesis induced by other antibiotics
(Kohanski et al., 2010; Thi et al., 2011). Interestingly, while
ciprofloxacin-induced mutagenesis is largely ROS-dependent
(Pribis et al., 2019; Rodriguez-Rosado et al., 2019), the mutation
signatures produced do not match the expected signature for
incorporation of 8-oxoguanine, an aberrant nucleotide that is
highly mutagenic toward DNA replication in vitro and is known
to accumulate in high ROS cells (Song et al., 2016). This
suggests that the primary contribution of ROS production
toward ciprofloxacin-induced mutagenesis is the triggering of
mutagenic DNA repair pathways, as opposed to mutagenesis
that results directly from oxidation of the nucleotide pool.

increased production of error-prone DNA polymerases. E. coli
produce three SOS-induced DNA polymerases (pols), pol II,
pol IV, and pol V (Goodman and Woodgate, 2013). Of these,
pols IV and V appear to be most responsible for
SOS-dependent antibiotic-induced mutagenesis, although
pol II can contribute to mutagenesis in some circumstances
(Cirz et al., 2005; Pribis et al., 2019).
Pol V is the most error-prone DNA pol produced in E.
coli cells (Jaszczur et al., 2016). Its activity is regulated at
multiple levels, ensuring that its activity in the absence of
exogenous DNA damage is minimal (Goodman et al., 2016).
At least three steps in the pol V regulation pathway are
dependent on RecA* nucleoprotein filaments (multimeric
filaments of RecA on single-stranded DNA), which are produced
during the repair of single-stranded DNA gaps and doublestrand breaks via homologous recombination (Goodman et al.,
2016). First, pol V is assembled from the products of an
SOS-regulated operon, umuDC (Tang et al., 1999; Fernandez
de Henestrosa et al., 2000). Induction of the SOS response
occurs when RecA* nucleoprotein filaments induce autocatalytic
cleavage of the SOS repressor protein LexA (Maslowska et al.,
2019). Thus, the UmuD2 (UmuD homodimer) and UmuC
proteins are only expressed once RecA* accumulates in cells.
At this stage, however, UmuD2 and UmuC do not form an
active polymerase. Second, UmuD2 homodimers undergo
autocatalytic cleavage in the presence of RecA*, in a mechanism
analogous to that of LexA (Goodman et al., 2016). This cleavage
produces the shorter protein UmuD'2. Whereas UmuD2 and
UmuD'2 are relatively stable, the intermediate heterodimer form
UmuDD' is rapidly degraded by the ClpXP protease, which
imparts a form of threshold on the RecA*-mediated conversion
of UmuD2 to UmuD'2 (Gonzalez et al., 1998). Third, RecA*
is again required to form the active version of pol V, known
as pol V Mut. UmuD'2 and UmuC physically interact to form
pol V; however, this complex is a very poor polymerase (note
that in this context pol V specifically refers to the complex
UmuD'2C; Goodman et al., 2016). In a remarkable feat of
biochemistry, pol V next locates a RecA* filament and extracts
a single RecA protomer, with ATP intact, from the 3' proximal
end (Goodman et al., 2016). This process forms the mutagenically
active complex pol V Mut (UmuD'2C-RecA-ATP; Jiang et al.,
2009). Once formed, pol V Mut remains active for only a few
seconds before cleaving the ATP (via intrinsic ATPase activity;
an unprecedented function among polymerases; Erdem et al.,
2014; Jaszczur et al., 2019), at which point the complex becomes
inactive (Goodman et al., 2016).
Microscopy is already beginning to play a major role in
improving our understanding of these polymerases in bacteria
(Joseph and Badrinarayanan, 2020). Using single-molecule
fluorescence microscopy, we visualized the RecA*-dependent
activation of pol V in cells treated with DNA damaging agents,
including ciprofloxacin (Robinson et al., 2015; Henrikus et al.,
2020). In doing so, we discovered yet another element that
controls pol V activity – spatial regulation (Figure 3A; Robinson
et al., 2015). While spatial regulation has been well-established
in eukaryotic systems, this was the first example of a DNA-acting
enzyme being spatially regulated in bacteria. In the case of

MOLECULAR MECHANISMS OF
ANTIBIOTIC-INDUCED MUTAGENESIS:
ACTIVATION OF SOS AND
ERROR-PRONE DNA POLYMERASES
The most widely studied form of antibiotic-induced
mutagenesis is associated with the SOS response and involves
Frontiers in Microbiology | www.frontiersin.org
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A

C

B

D

E

FIGURE 3 | Recent insights into the activities of error-prone DNA polymerases in bacterial cells. (A,B) Single-molecule fluorescence microscopy analysis of DNA
polymerase V in E. coli cells carrying UV-induced DNA damage. Figures adapted from Robinson et al. (2015). (A) DNA polymerase V is a rare example of a spatially
regulated polymerase enzyme in bacteria, with intermediate forms being localized to the cell membrane and only the fully activated form being allowed to redistribute
into the cytosol. The active form of DNA polymerase V, pol V Mut, is comprised of two molecules of UmuD', one molecule of UmuC, one molecule of RecA, and one
molecule of ATP (i.e., UmuD'2-UmuC-RecA-ATP; Jiang et al., 2009). The formation of pol V Mut is regulated at several levels, in order to minimize pol V-dependent
mutagenesis in the absence of DNA damage (Goodman et al., 2016). All stages of pol V regulation involve activities of RecA* nucleoprotein filaments. A single-molecule
fluorescence microscopy analysis of cells expressing a fluorescent protein fusion of UmuC (UmuC-mKate2), revealed three stages in the activation of pol V in cells
treated with a burst of UV light (Robinson et al., 2015). In phase I, cells began to grow into filaments, indicating induction of the SOS response, but produced little
UmuC-mKate2. In phase II, cells began to express UmuC-mKate2. In this phase, UmuC-mKate2 was localized to the cell membrane. Due to the small number of
UmuC-mKate2 features present in each cell, this can be difficult to see in individual representative images, but becomes abundantly clear in statistical analyses of cells
across multiple images. Membrane localization is most evident in the image labeled “peak intensity”, where clear membrane-associated signals are visible along the
edge of the cell. Finally, in phase III, UmuC-mKate2 was released into the cytosol as pol V Mut, where it formed punctate foci on the nucleoid, indicative of DNA
synthesis occurring. This can be seen most clearly in the image labeled “peak + 30 min”. Release of UmuC from the membrane requires the cleavage of the UmuD
protein to its shorter form UmuD'. (B) Pol V Mut rarely colocalises with replisomes. Contrary to existing models of pol V-dependent DNA synthesis, in which pol V
carries out translesion synthesis at stalled replication forks, single-molecule fluorescence imaging revealed that pol V Mut rarely colocalises with replication forks. This
indicates that pol V likely works on other DNA substrates in cells, which may include single-stranded gaps and/or recombination intermediates. (C–E) DNA polymerase
IV (pol IV) works on double-strand break repair intermediates in cells treated with ciprofloxacin. (C) Single-molecule fluorescence microscopy demonstrated that
fluorescently labeled pol IV forms foci that colocalise with sites of double-strand breaks induced by the SceI restriction enzyme. Figure adapted from Mallik et al. (2015).
(D) A second single-molecule imaging study demonstrated that the formation of pol IV foci in cells treated with either ciprofloxacin or trimethoprim requires processing
of double-strand breaks by the RecBCD complex. Figure adapted from Henrikus et al. (2020). This, together with other evidence, indicates that these foci likely
represent pol IV working on recombination intermediates during double-strand break repair. (E) Ciprofloxacin-induced mutagenesis is a form of error-prone doublestrand break repair, requiring induction of the SOS and RpoS responses (regulated by lexA and rpoS), double-strand break repair (dependent on recA, recB, recC, and
ruvC), and error-prone DNA polymerases (Pols II, IV, and V). Figure adapted from Pribis et al. (2019). Crucially, the RpoS response is only induced in a sub-population
of cells, indicating that ciprofloxacin-induced mutation rates are elevated within only a fraction of the cell population (~10%).

pol V, spatial regulation is imposed via an interaction between
UmuC and the inner cell membrane. Following SOS-induced
expression of UmuD2 and UmuC, but prior to UmuD′2 being
formed, UmuC associates with the membrane. Once UmuD′2
is formed, UmuC is released from the membrane as part of
either pol V (UmuD′2C) or pol V Mut (UmuD′2C-RecA-ATP).
It remains unknown whether pol V Mut formation occurs on
the membrane or in the cytosol. In the microscopy images,
pol V spatial regulation presents as a redistribution of
fluorescently labeled UmuC from the membrane to the cytosol.
Due to the fact that UmuC is expressed at very low levels in
E. coli (0–15 mol/cell; Robinson et al., 2015), UmuC produced
patchy signals and this spatial redistribution was difficult to
observe by eye, but was well-supported by statistical analyses.

Frontiers in Microbiology | www.frontiersin.org

In subsequent work, we developed a novel image-analysis
technique that enabled us to extract the relative proportion
of membrane-bound and cytosolic UmuC as a function of
time (Goudsmits et al., 2016). As UmuC levels peak, 90% of
the protein is associated with the membrane. Within 30 min,
this proportion decreases to 50%, with the remaining 50%
now appearing in the cytosol. As pol V Mut is formed and
begins to work on the DNA within the cytosol, punctate foci
of UmuC are formed. This phenomenon is known as detection
by localization and occurs because the rate of diffusional motion
slows dramatically once the protein binds to the DNA.
Interestingly, we observed that pol V Mut foci formed at sites
on the nucleoid that were spatially distinct from replisomes
(Figure 3B). This strongly suggests that pol V Mut acts on
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non-replisomal substrates, such as single-stranded DNA gaps
or homologous recombination intermediates (Robinson et al.,
2015). In a follow-up study, we observed that the number of
pol V Mut foci formed in ciprofloxacin-treated cells did not
appear to correlate with the number of double-strand breaks
present, indicating that the substrates for pol V Mut are unlikely
to be homologous recombination intermediates formed during
double-strand break repair (Henrikus et al., 2020).
In contrast, recent studies have revealed a clear role in
double-strand break repair for the other error-prone polymerase
present in E. coli, pol IV. A role for pol IV in (error-prone)
break repair was originally discovered through genetics
experiments (Ponder et al., 2005). The single-molecule imaging
measurements described below demonstrated that break-repair
intermediates are the major substrates for pol IV in cells treated
with (fluoro)quinolone antibiotics.
While many had tried, the Foster group was the first to
produce a functional fluorescent protein fusion of pol IV (Mallik
et al., 2015). This was a considerable achievement as assaying
for pol IV-dependent activities in cells is non-trivial. Furthermore,
the activity of fusions turns out to be highly sensitive to the
length of the linker used to connect the pol IV protein (DinB)
to the fluorescent protein. Using the active (20 amino-acid
linker) fusion they showed, among other things, that pol IV
localizes as punctate foci in cells treated with the quinolone
antibiotic naladixic acid (Mallik et al., 2015). These foci tightly
colocalised with RecA* foci, which are expected to form at
sites of double-strand breaks. Using a restriction enzyme to
induce a single break within the chromosome, they observed
that pol IV localized to the break site (Figure 3C). Building
on this work, we showed that the binding of pol IV to the
nucleoid in cells treated with ciprofloxacin or trimethoprim
was strongly dependent on a gene (recB) involved in doublestrand break repair (Henrikus et al., 2020). Disruption of the
RecBCD complex, which carries out the early stages of doublestrand break repair, almost completely abolished the formation
of pol IV foci in cells treated with either ciprofloxacin or
trimethoprim (Figure 3D). Together with existing evidence
from genetics and biochemistry studies (Ponder et al., 2005;
Williams et al., 2010; Shee et al., 2011a,b, 2012; Pomerantz
et al., 2013a,b; Tashjian et al., 2019), these microscopy
observations indicated that a major role of pol IV in cells is
to act in double-strand break repair. The likely function for
pol IV in this context is the extension of D-loop structures.
Using a combination of microscopy and classical genetics
approaches, the Rosenberg group recently demonstrated that
ciprofloxacin-induced mutagenesis is ROS-dependent, and is
driven by error-prone double-strand break repair (Pribis et al.,
2019). Ciprofloxacin-induced mutagenesis was found to
be dependent on genes encoding pols II, IV, and V (polB,
dinB, and umuDC), double-strand break repair factors (recA,
recB, and ruvC), the SOS response (mutagenesis was blocked
in a lexA [Ind−] background), and the RpoS response (Figure 3E;
the RpoS response is introduced in greater detail in the next
section). The authors discovered that ROS levels were elevated
in a sub-population (~10%) of ciprofloxacin-treated cells. Elevated
mutagenesis was strongly enriched within this sub-population.
Frontiers in Microbiology | www.frontiersin.org

In this context, the main function of ROS is to induce the
RpoS response; mild overexpression of RpoS alleviated the
requirement for ROS in the mutagenesis assays. The observation
of an RpoS-high sub-population is an example of phenotypic
heterogeneity. Microscopy is revealing phenotypic heterogeneity
to be a common theme bacterial DNA repair and mutagenesis
(Vincent and Uphoff, 2020). Improving our understanding of
population heterogeneities is vital if we are to better understand
antibiotic-induced mutagenesis.
Whereas, the Rosenberg study points to pol IV-dependent
error-prone break repair occurring in a subset of high-ROS,
RpoS-positive cells (Pribis et al., 2019), our imaging study
showed that ciprofloxacin-induced pol IV foci formed in all
cells (Henrikus et al., 2020). The model that is most consistent
with the data is that pol IV is involved in double-strand break
repair in all cells and that this somehow becomes error-prone
in the RpoS-positive sub-population. In other words, the RpoS
response modulates the fidelity of pol IV, rather than its ability
to engage double-strand break repair intermediates. The role
of RpoS in mutagenesis remains unknown, however, it is
tempting to speculate that RpoS-dependent modulation of
mismatch repair could play a role, as has been reported in
other systems (Gutierrez et al., 2013).

MOLECULAR MECHANISMS OF
ANTIBIOTIC-INDUCED MUTAGENESIS:
RpoS RESPONSE AND REGULATION OF
MISMATCH REPAIR
Using classical genetics approaches, the Matic group discovered
that cells treated with the β-lactam antibiotic ampicillin induced
pol IV-dependent mutagenesis (Gutierrez et al., 2013). As with
the ciprofloxacin-induced mutagenesis (Pribis et al., 2019)
described in the previous section, the RpoS response was found
to play a key role in ampicillin-induced mutagenesis (Gutierrez
et al., 2013). The RpoS response (also known as the σS response
or general stress response) is induced under a variety of
circumstances, including stationary growth, starvation, and
oxidative damage (Battesti et al., 2011; Gottesman, 2019). The
protein RpoS (or σS) is an alternative σ-factor that governs
the expression of hundreds of different genes (Battesti et al.,
2011). When expressed, RpoS competes with the housekeeping
σ-factor, σ70 (or RpoD), for binding to RNA polymerase, and
in doing so dramatically changes the gene expression profile
of the cell (Battesti et al., 2011).
The Matic group showed that representative quinolone,
β-lactam, and aminoglycoside antibiotics induced the RpoS
response (Gutierrez et al., 2013). Choosing to investigate
ampicillin in greater depth, they demonstrated that ampicillininduced mutagenesis required both pol IV and induction of
the RpoS response. Unlike ciprofloxacin-induced mutagenesis,
induction of the SOS response was not required for ampicillininduced mutagenesis. They also observed that mild overexpression
of the mismatch repair protein MutS (which functions to
recognize nucleotide mismatches) completely suppressed
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mutagenesis. This led to the discovery of a small regulatory
RNA, SdsR, which is expressed during the RpoS response and
reduces the expression of MutS. They proposed a model in
which depletion of mismatch repair leads to less efficient repair
of mismatches produced by pol IV, which in turn leads to
increased mutagenesis.
Representative quinolones and aminoglycosides also induce
the RpoS response (Gutierrez et al., 2013) and exhibit pol
IV-dependent mutagenesis (Thi et al., 2011). It is reasonable
to speculate that the depletion-of-mismatch-repair mechanism
at play during ampicillin-induced mutagenesis may extend to
other bactericidal antibiotics. A single-molecule/single-cell
imaging approach that would seemingly provide the ideal
platform on which to test this idea has already been developed.
Elez developed an approach that allowed mismatches to
be visualized by microscopy (Elez et al., 2012). By fluorescently
labeling the mismatch repair protein MutL (the molecular
coordinator of mismatch repair), it became possible to visualize
the process of mismatch detection by the MutS and MutL
proteins. Each time a mismatch was detected, a punctate MutL
focus became visible in microscope images. In a series of later
studies, Elez and colleagues repeated the measurements in cells
that lacked the mutH gene, which is required for repair of
the mismatch (Elez et al., 2010, 2018; Robert et al., 2018).
This ensured that the mismatch would be fixed to a mutation
in the next round of DNA replication, providing a means to
infer mutation rates in real-time.

While it was not the primary goal his study
(Uphoff, 2018), Stephan Uphoff used the labeled-MutL system
to study mismatch-detection rates in cells treated with the
fluoroquinolone antibiotic norfloxacin (Figure 4). Growing
the cells in a single-cell chemostat device called a “mother
machine” (Figure 4A; Wang et al., 2010), he observed a
significant increase in the number of mismatches detected
in cells by fluorescent MutL (Uphoff, 2018). Delivering a
pulse of norfloxacin at a concentration equal to the MIC,
a transient 5-fold increase in the number of detected
mismatches was observed (Figure 4B). Delivering a lower
concentration (0.25x MIC) for a longer time led to a more
sustained elevation (3-fold) of the mismatch-detection rate.
In both experiments, induction of the SOS was also measured,
revealing that changes in the mismatch-detection rate correlated
with induction of the SOS response. The MutL-based mismatchdetection system could be an extremely useful tool in the
study of antibiotic-induced mutagenesis. In particular, it would
allow the role of RpoS-based regulation of mismatch repair
to be assessed much more broadly and at an unprecedented
level of detail. Each MutL focus represents a mismatch that
would normally be repaired before becoming fixed as a
mutation. One would hypothesize that disruption of the RpoS
response would prevent the down-regulation of MutS, leading
to more efficient detection of mismatches and a corresponding
increase in the number of MutL foci detected in cells treated
with antibiotics.

B
A

FIGURE 4 | Direct detection of mismatches in E. coli cells treated with norfloxacin. (A,B) A single-molecule fluorescence microscopy study of cells growing in
microfluidic chemostats revealed an increased rate of mismatches in cells treated with the fluoroquinolone antibiotic norfloxacin. Figures adapted from Uphoff (2018).
(A) A microfluidic “mother machine” was used to monitor individual cells through multiple generations. A fluorescent protein fusion of the mismatch repair protein
MutL (MutL-mYPet) allowed mismatches to be visualized as punctate foci within cells. (B) Treatment of cells with norfloxacin induces a substantial increase in
mismatch rate. Left unrepaired, these mismatches would become mutations during the subsequent round of DNA replication. The dynamics of mismatch formation
match well with induction of the SOS response, which is monitored in this study by expression of cyan fluorescent protein (CFP) from the SOS-inducible dinB
promoter (pDinB-CFP). Importantly, both SOS induction and the elevated mismatch rate lag behind cell death – increased mutagenesis is likely to occur in a small
number of cells that survive beyond the initial stages of treatment.
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MEASUREMENTS LINKING MUTATIONS
TO CELL AND POPULATION
OUTCOMES

cells were physically isolated from each other within the mother
machine, there was no competition between variants in the
population and thus, growth rate measurements directly reflected
the fitness of the mutants in the conditions tested. Approximately,
~20,000 individual mutation events were detected over 200
generations. The measurements revealed that the majority of
mutations observed in this experiment were quasi-neutral, having
little, or no effect on fitness. Only 1% of mutations were lethal.
Accurately measured distributions of fitness effects are key to
evolutionary modeling and would be particularly advantageous
in the modeling of antibiotic-resistance development. If the mother
machine format could be adapted for use with antibiotics, this
might even represent a route toward a quantitative assessment
of the role of antibiotic-induced mutagenesis in the evolution of
antibiotic resistance. Because the technique is based on microscopy,
multiple facets of antibiotic-induced mutagenesis could
be monitored in parallel. In addition to mismatch rates and cell
growth rates, cell filamentation and cell death could also
be monitored. With appropriate probes already in hand, it should
be also possible to observe induction of the SOS and RpoS
responses and corresponding activities of error-prone pols IV and V.
What might evolution to antibiotic resistance look like under
the microscope? A 2015 study by Bos et al. (2015) provides
some clues. As highlighted earlier (Figure 2), the authors
observed that cells treated with ciprofloxacin at 0.125x MIC
grow into filaments that contain multiple nucleoid masses (Bos
et al., 2015). Occasionally, the authors observed regular-sized
cells budding from the tip of these filaments (Figure 5B).
Most of the time these buds were inviable, however, buds
were occasionally produced that grew normally. These cells
did not grow into filaments, indicating that they had become
resistant to the antibiotic. Expansion of these resistant variants
at 0.5x MIC or 1x MIC ciprofloxacin, followed by sequencing
of the gyrA and marR loci, confirmed the presence of resistance
mutations in many of the variants (in other cases, resistance
was assumed to occur via mutations at other loci that were
not sequenced). Expansion at 1x MIC strongly favored the
gyrA (S83A) mutation, which appeared in 7/8 isolates. The
Bos et al. (2015) study indicates that antibiotic-resistant variants
can appear frequently enough to be detected via microscopy.

The mismatch-detection approach developed by Elez would also
be an ideal platform to begin connecting the molecular world
of mutagenesis with changes at the cell and population levels.
In fact, her group has already taken steps in this direction,
measuring a key population-level descriptor, the distribution
of fitness effects, and for cells growing in microfluidic mother
machines (Robert et al., 2018). These devices allow for longterm measurements to be made under precisely controlled
experimental conditions. The group monitored mismatch detection
by MutL in a mismatch repair-defective mutH strain so that
mismatches would be fixed as mutations in subsequent round
of DNA replication (Figure 5A). In parallel, they tracked cell
growth rates, enabling them to link the appearance of spontaneous
mutations in cells with changes in growth rate. Because the

A

B

MEASUREMENTS LINKING CELL
GROWTH DYNAMICS TO POPULATION
OUTCOMES

FIGURE 5 | Microscopy measurements linking mutations with phenotypic
changes. (A) Direct measurement of a distribution of fitness effects from
E. coli cells growing in a microfluidic chemostat. Figure adapted from
Robert et al. (2018). Mismatches were detected using a fluorescent protein
fusion of the mismatch repair protein MutL (YFP-MutL). Foci were produced in
cells whenever YFP-MutL bound to a mismatch. The cells also carried a
deletion of the mutH mismatch repair gene, ensuring that all mismatches
became mutations in the subsequent round of DNA replication. The
experimenters were able to link the appearance of mutations with changes in
cell growth rates. They were able to produce a well-sampled distribution of
fitness effects. Contrary to the dogma that most mutations are deleterious,
the distribution showed that the vast mutations were quasi-neutral, having
very little effect on growth. Only 1% of mutations were lethal. (B) Time-lapse
microscopy captures the moment a ciprofloxacin-resistant cell buds from
filamentous, multinucleate E. coli cell growing in a sub-inhibitory concentration
of ciprofloxacin. Figure adapted from Bos et al. (2015).

Frontiers in Microbiology | www.frontiersin.org

Antibiotics can induce mutagenesis, tolerance, and cell death.
Evolution to antibiotic resistance is often limited by the mutation
supply rate, which is a product of the cellular mutation rate
and the size of the population (Hughes and Andersson, 2017).
Elevated mutagenesis acts to increase the mutation supply,
while cell death reduces it by decreasing the size of the
population. Seeking to minimize the effects of cell death,
antibiotic-induced mutagenesis is typically studied using sub-MIC
concentrations of antibiotic. Importantly, it was demonstrated
recently that significant cell death still occurs in this sub-MIC
regime. Through a combination of microscopy, plate-reader
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Evidence of this is visible in Uphoff ’s work with sub-MIC
norfloxacin (Uphoff, 2018), where the number of viable cells
decreases continuously throughout the experiment (Figure 4B).
Presumably, this has occurred because of the small and finite
size of the channels in the mother machine. Cells that are
growing do not increase the size of the population being
monitored because cells that no longer fit in the channel are
washed away and thus are no longer monitored. Cells that
die decrease the size of the observed population. Eventually,
none of the channels would contain any viable cells. All of
this occurred more quickly in cells treated with norfloxacin
concentrations equivalent to the MIC because cells die more
often. Because Uphoff monitored mismatch formation and cell
death simultaneously we can carry out a putative assessment
of the effects of norfloxacin exposure on mutation supply. In
measurements with 1x MIC norfloxacin, mismatch-detection
rates increased while cell viability fell (Figure 4B). At its peak,
mismatch-detection rates were ~5x above basal levels (Figure 4B;
lower left panel; three generation times). At this time point,
however, survival had dropped to 10% of the original value
(Figure 4B; upper left panel; three generation times). If we take
the product of these two values as a crude approximation of
the mutation supply rate within the mother machine device,
mutation supply would have fallen by 50% in the norfloxacinexposed population. In the measurements with 0.25x MIC
norfloxacin, cell viability decreased more slowly (Figure 4B;
upper right panel). By the five generations time-point, viability
had reduced to 50% (Figure 4B; upper right panel), while
the mismatch-detection rate had increased ~2.5x (Figure 4B;
lower right panel). Thus, the mutation supply at this time
would be predicted to be higher (125%) than that of the initial
population. At a later time-point (eight generation times), the
mutation supply would have been lower than the starting
population; the mismatch-detection frequency had increased
3x, however, cell survival was only ~15%. The effects of cell
death are amplified in the mother machine format, however,
the fact that mismatch-detection frequencies and cell survival
rates change as a function of time after drug exposure highlight
the need for simultaneous, real-time measurements of mutation
rates, and cell growth/death parameters. Such measurements
are vital if we are to improve our understanding of antibioticinduced mutagenesis. Bacterial population sizes are also affected
by non-genetic phenomena, such as antibiotic tolerance and
persistence. Accurate measurements of cell growth and survival
would also provide new opportunities to assess the roles of
antibiotic tolerance and persistence in the development of
antibiotic resistance mutations.

FIGURE 6 | Antibiotic-induced population fluctuations. It is well known that
when bacterial growth is monitored as a function of antibiotic concentration,
population growth rates tend to slow as the minimum inhibitory concentration
(MIC) is approached. Recently, it was discovered that for bactericidal
antibiotics this reduction in the net growth of the population is caused not by
the slowing of cell division, but by some of the cells dying (Coates et al., 2018).
As the MIC is approached, the rate of cell death approaches that of cell
division. This is neatly visualized by a time-lapse movie, which shows cells
undergoing stochastic cell death when growing at a concentration of
cefsulodin equivalent to 0.8x MIC. Live and dead cells can be distinguished by
contrast. The live cells produce high contrast in the bright-field images,
whereas the dead cells, which have lysed and have left behind an empty cellshaped sac, produce only low image contrast. At various points in the movie,
a portion of the population undergoes stochastic cell death. These population
fluctuations have far-reaching implications for the study of antibiotic-induced
mutagenesis and for its potential to supply antibiotic resistance mutations.
Figure adapted from Coates et al. (2018).

assays, and modeling, the Kim group investigated the extinction
of small populations of cells (<100) upon treatment with
antibiotics (Coates et al., 2018). Their analysis revealed that
bactericidal antibiotics induced stochastic fluctuations in
population size. This was visualized by time-lapse microscopy
images of cells growing in the presence of the cephalosporin
antibiotic cefsulodin, at a concentration equivalent to 0.8x MIC
(Figure 6). During the course of the time-lapse measurement,
the total number of cells that are present increases, however,
this occurs more slowly than in the absence of drug because
many of the cells die. Stochastic cell death leads to marked
fluctuations in the population size as a function of time. This
simple observation has broad ramifications for the study of
antibiotic-induced mutagenesis.
The fact that population growth in this near-MIC regime is
the product of both cell growth and cell death means that
many more generations are required for the population to reach
a certain size than would be required in the absence of drug.
When rates of antibiotic-induced mutagenesis are measured using
fluctuation analyses, the results are reported in units of mutations
per genome per generation. Typically, the number of generations
is calculated based on the population size after treatment, under
the assumption that cells are not dying when the antibiotic
concentration is below the MIC. In light of the stochastic
population dynamics reported by the Kim group, it appears
that many of the mutation rates reported in the literature may
be overestimated because more generations occurred than were
accounted for in the measurements (Frenoy and Bonhoeffer, 2018).
The second important ramification of stochastic population
dynamics for the study of antibiotic-induced mutagenesis is that
when the population size is small, as would be the case in a
mother machine for example; many populations will become extinct
when exposed to sub-MIC concentrations of bactericidal antibiotics.
Frontiers in Microbiology | www.frontiersin.org

CONCLUDING REMARKS
The studies highlighted throughout this review demonstrate
the potential of microscopy in helping to achieve a more
thorough understanding of antibiotic-induced mutagenesis.
There is enormous potential for other types of correlative
measurements as well. Microscopy shows a great degree of
promise as an important platform for uncovering functional
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